This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Asymbescaline" – news · newspapers · books · scholar · JSTOR (August 2019)

Asymbescaline
Names


Preferred IUPAC name 2-(3,4-Diethoxy-5-methoxyphenyl)ethan-1-amine
Other names 3,4-Diethoxy-5-methoxyphenethylamine
Identifiers
CAS Number	63918-08-1^Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL124125^Y
ChemSpider	41279^Y
PubChem CID	45367
UNII	F5H6Z6VQ2Z^Y
CompTox Dashboard (EPA)	DTXSID20213690
InChI InChI=1S/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3^Y Key: VFOAVFQWZYUFQZ-UHFFFAOYSA-N^Y InChI=1/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3 Key: VFOAVFQWZYUFQZ-UHFFFAOYAI
SMILES O(c1c(OC)cc(cc1OCC)CCN)CC
Properties
Chemical formula	C₁₃H₂₁NO₃
Molar mass	239.315 g·mol⁻¹
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Y verify (what is ^YN ?) Infobox references

Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours.^[1] Asymbescaline produces few to no effects.^[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.

See also

References